Connect with us

PR Newswire

QS World University Rankings 2022

Published

on

LONDON, 8 de junio de 2021 /PRNewswire/ — QS Quacquarelli Symonds, analista a nivel internacional de educación superior, ha publicado hoy la decimonovena edición del ranking universitario internacional más consultado del mundo. La universidad líder de Argentina, la Universidad de Buenos Aires (UBA), ha sido nombrada la mejor universidad del continente por séptimo año consecutivo. Se sitúa en el puesto 69 a nivel global.

QS World University Rankings 2022: Top-10 Latinoamérica

2022

2021

Institución

Localización

69

66

Universidad de Buenos Aires

Argentina

105=

100

Universidad Nacional Autónoma de México (UNAM)

México

121=

115

Universidade de São Paulo (USP)

Brasil

135

121

Pontificia Universidad Católica de Chile

Chile

161=

155

Tecnológico de Monterrey (ITESM)

México

183=

180

Universidad de Chile

Chile

219

233

Universidade Estadual de Campinas (Unicamp)

Brasil

236=

227

Universidad de Los Andes Colombia

Colombia

258=

259

Universidad Nacional de Colombia

Colombia

322=

326

Pontificia Universidad Católica Argentina Santa María de los Buenos Aires (UCA)

Argentina

© QS Quacquarelli Symonds 2004-2021 https://www.TopUniversities.com/.  

Todos los derechos reservados.

  • Tanto académicos como empleadores de todo el mundo, cuyos conocimientos contribuyen a los resultados, nombran a la UBA como una de las 50 mejores universidades del mundo. Recibe el 44º mejor puntaje en el indicador de Reputación Académica de QS con una puntuación de 90.2 / 100, y el 40º mejor puntaje de los empleadores, con un puntaje de 93.4 / 100. Sus puntuaciones para ambos indicadores tienen una tendencia al alza.
  • Con 24 instituciones clasificadas, Argentina es la segunda nación latinoamericana más representada. Solo Brasil (27 universidades destacadas) tiene un número más alto. Sin embargo, una mayor proporción de universidades argentinas ha disminuido durante el último año.
  • Los resultados muestran que la universidad española mejor clasificada, la Universitat de Barcelona (UB), sube quince puestos. La UB ahora se ubica en el lugar 168, 39 puestos más altos que la siguiente institución mejor clasificada del país.
  • En total aparecen 29 universidades españolas en el ranking, tres más que en la edición del año pasado. De esas 29 instituciones clasificadas: 10 mejoran su posición, 10 descienden de rango, y 9 permanecen estables.
  • Dos universidades chilenas mantienen sus puestos dentro del top-200 global. Sin embargo, la principal universidad de Chile, la Pontificia Universidad Católica de Chile, no logra mejorar el desempeño récord del año pasado. Ocupa el lugar 135, y junto a ella en el top 200 la Universidad de Chile (183).
  • Ocho nuevas universidades colombianas entran este año dentro del ranking, lo que significa que Colombia disfruta ahora de su mayor nivel de representación, hasta el momento, en el QS World University Rankings. En total, 19 universidades del país aparecen en el ranking entre las 1300 mejores del mundo.
  • La universidad líder de México, la Universidad Nacional Autónoma de México, es nominada la segunda mejor universidad de Latinoamérica. Sin embargo, no ha conseguido mejorar su récord de desempeño del año pasado. Se coloca en el puesto 105, y se encuentra dentro del Top-200 junto con el Tecnológico de Monterrey (161, quinta en Latinoamérica).
  • Los resultados muestran que la Pontificia Universidad Católica del Perú (PUC del Perú), entra en el Top-400 global por primera vez en la historia del QS World University Rankings. Se coloca en el puesto 395.

En total, QS clasifica a 151 países latinoamericanos, de 16 naciones del continente. De estos 151

  • 20 han mejorado su clasificación en el último año.
  • 46 han bajado de rango.
  • 66 han permanecido estables dentro de su rango o banda.
  • 19 son nuevos en la clasificación.

Ben Sowter, Director de Investigación de QS, dijo: “El QS World University Rankings 2022 ofrece algunos indicios de que las mejores universidades de América Latina están disfrutando de un mayor reconocimiento entre los académicos y los empleadores que responden a nuestras encuestas. De hecho, diecinueve de las veinte mejores universidades del continente han mejorado su puntuación de reputación académica en el último año. Aunque esto es indudablemente prometedor, sigue siendo cierto que las mejoras generales se verán circunscritas hasta que las instituciones latinoamericanas vean una mayor proporción de sus investigaciones publicadas en revistas de alto impacto y, de hecho, sean más citadas por la comunidad académica”.

Sowter continuó: “Existen modelos a seguir en este sentido, especialmente en Asia: un modelo que implica altos niveles de compromiso internacional, internacionalización institucional y un énfasis en la colaboración transfronteriza en materia de investigación. Dado que QS registra sistemáticamente una baja proporción de profesores internacionales en esta cohorte continental, un primer paso necesario es poner remedio a esta situación mediante una estrategia y una política diseñadas para atraer a académicos con talento del extranjero.”

Massachusetts Institute of Technology logra un récord por décimo año consecutivo como número uno del mundo.

QS World University Rankings 2022: Top-20 Global

2022

2021

Nombre de la institución

Localización

1

1

Massachusetts Institute of Technology (MIT)

Estados Unidos

2

5

University of Oxford

Reino Unido

  3=

2

Stanford University

Estados Unidos

  3=

7

University of Cambridge

Reino Unido

5

3

Harvard University

Estados Unidos

6

4

California Institute of Technology (Caltech)

Estados Unidos

7

8

Imperial College London

Reino Unido

  8=

6

ETH Zurich (Swiss Federal Institute of Technology)

Suiza

  8=

10

UCL (University College London)

Reino Unido

10

9

University of Chicago

Estados Unidos

11

11

National University of Singapore (NUS)

Singapur

12

13

Nanyang Technological University (NTU)

Singapur

13

16

University of Pennsylvania

Estados Unidos

  14=

14

Ecole Polytechnique Fédérale de Lausanne (EPFL)

Suiza

  14=

17

Yale University

Estados Unidos

16

20

University of Edinburgh

Reino Unido

17

15

Tsinghua University

China

18

23

Peking University

China

19

19

Columbia University

Estados Unidos

20

12

Princeton University

Estados Unidos

© QS Quacquarelli Symonds 2004-2021 https://www.TopUniversities.com/Todos los derechos reservados

Metodología

QS utiliza seis indicadores para compilar su ranking:

  1. Reputación académica: basado en las respuestas de la encuesta de más de 130.000 académicos.
  2. Reputación de los empleadores: basado en las respuestas de la encuesta de más de 75.000 empleadores sobre la relación entre la institución y la empleabilidad de los graduados.
  3. Citas por profesor: mide el impacto de la investigación. Divide el número total de citas recibidas por los trabajos de investigación de una universidad durante un periodo de 5 años entre el número de profesores de esa institución.
  4. Ratio profesor/estudiante: mide la capacidad de enseñanza. El número de estudiantes se divide por el número de profesores, ofreciendo a la comunidad educativa global un indicativo del tamaño de las clases en la institución seleccionada.
  5. Ratio profesores internacionales: una de las medidas de QS con relación a la internacionalización. Mide la proporción de profesores extranjeros en una institución.
  6. Ratio estudiantes internacionales: la segunda de las medidas de QS de internacionalización. Mide la proporción de estudiantes extranjeros en una institución. Este indicador además muestra la habilidad de las universidades en atraer talento diversas partes del mundo.

Puede encontrar más información sobre la metodología aquí: https://www.topuniversities.com/qs-world-university-rankings/methodology.

El Ranking completo se puede consultar en: www.TopUniversities.com a partir del martes 8 de junio a las 22:00 CEST.


Notas para los editores  

QS Quacquarelli Symonds  

QS Quacquarelli Symonds es el proveedor líder mundial en servicios, analíticas y estudios dentro del sector de la educación superior global, cuya misión es ayudar a personas motivadas de todo el mundo, a conseguir su máximo potencial a través de los logros académicos, movilidad internacional y desarrollo de carrera.

El conjunto de rankings QS World University Rankings, inaugurado en 2004, ha crecido hasta convertirse en la fuente comparativa más popular a nivel mundial sobre el desempeño de las universidades. Su principal website, www.TopUniversities.com – donde se alojan los rankings – fue visitada 147 millones de veces en 2020 y obtuvo más de 79.000 clippings de medios. Los informes de QS fueron publicados por medios de todo el mundo en 2020.    

Logo – https://mma.prnewswire.com/media/1503777/QS_World_University_Rankings_Logo.jpg  

FUENTE QS Quacquarelli Symonds

Related Links

http://www.qs.com/

SOURCE QS Quacquarelli Symonds

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.prnewswire.com:443/news-releases/qs-world-university-rankings-2022-806236140.html

PR Newswire

Oleochemicals Market|$ 9.01 billion growth expected during 2021-2025 | 17000+ Technavio Reports

Published

on

Technavio’s in-depth market research reports include value chain analysis and validation techniques to help industry leaders improve their business.
Download FREE Sample Report

The report on the oleochemicals market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by factors such as the growth of packaged food and beverage industry, the growing demand for soaps and detergents, and government initiatives regarding the use of oleochemicals.

The oleochemicals market analysis includes the product, application, and geography landscape segments. This study identifies the government initiatives regarding the use of oleochemicals as one of the prime reasons driving the oleochemicals market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The oleochemicals market covers the following areas:

Oleochemicals Market Sizing
Oleochemicals Market Forecast
Oleochemicals Market Analysis

Companies Mentioned

  • BASF SE
  • Cabot Corp.
  • Cargill Inc.
  • Croda International Plc
  • Emery Oleochemicals Group
  • IOI Corporation Berhad
  • Kao Corp.
  • KLK Oleo
  • The Procter and Gamble Co.
  • Wilmar International Ltd.

Related Reports on Materials Include:

Global Ink Resins Market– The ink resins market size is segmented by process (lithography printing, flexography printing, gravure printing, and others) and geography (APAC, Europe, North America, MEA, and South America).
Download FREE Sample Report

Global Emulsion Polymers Market– The emulsion polymers market is segmented by application (paints and coatings, paper and paperboard coatings, adhesives, and others) and geography (APAC, North America, Europe, South America, and MEA).
Download FREE Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020- 2025

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Fatty acids – Market size and forecast 2020-2025
  • Fatty alcohol – Market size and forecast 2020-2025
  • Glycerol – Market size and forecast 2020-2025
  • Fatty amines – Market size and forecast 2020-2025
  • Others – Market size and forecast 2020-2025
  • Market opportunity by Product

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Soaps and detergents – Market size and forecast 2020-2025
  • Polymers – Market size and forecast 2020-2025
  • Personal care and pharmaceuticals – Market size and forecast 2020-2025
  • Lubricants and greases – Market size and forecast 2020-2025
  • Others – Market size and forecast 2020-2025
  • Market opportunity by Application

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • APAC – Market size and forecast 2020-2025
  • North America – Market size and forecast 2020-2025
  • Europe – Market size and forecast 2020-2025
  • MEA – Market size and forecast 2020-2025
  • South America – Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • BASF SE
  • Cabot Corp.
  • Cargill Inc.
  • Croda International Plc
  • Emery Oleochemicals Group
  • IOI Corporation Berhad
  • Kao Corp.
  • KLK Oleo
  • The Procter and Gamble Co.
  • Wilmar International Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Newsroom:  https://www.technavio.com/news/oleochemicalsmarket
Report Page: https://www.technavio.com/report/oleochemicals-market-industry-analysis

SOURCE Technavio

Related Links

https://www.technavio.com/report/oleochemicals-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T41-v1_wk26_005_&utm_content=IRTNTR70600

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.prnewswire.com:443/news-releases/oleochemicals-market-9-01-billion-growth-expected-during-2021-2025–17000-technavio-reports-301315819.html

Continue Reading

PR Newswire

Top Italian Bank, Credem Goes Live with Temenos Infinity in the Cloud to Deliver Frictionless Digital Experiences

Published

on

  • Temenos Infinity powers rapid time-to-market for new digital banking experiences, starting from a brand new mobile app for Retail and SME customers
  • New app enables Credem to greatly improve its customer experience and achieve a first-class omnichannel experience

GENEVA, Switzerland, June 22, 2021 /PRNewswire/ — Temenos (SIX: TEMN), the banking software company, today announced that Credito Emiliano S.p.A. (Credem), one of the top 10 banks in Italy, has gone live with a new mobile app, based on cloud-native Temenos Infinity, to accelerate its digital banking strategy. Temenos Infinity, running on the public cloud, will make it quicker and easier for Credem to develop frictionless, personalized, and secure digital banking services that will help it attract new customers and drive long-term customer loyalty.

Credem has already launched a fully renewed new mobile app developed in just nine months using Temenos Infinity. The new app offers a basic set of features for personal customers and, thanks to the speed granted by Temenos Infinity, will be enriched with new features in a continuous improvement approach. A small business version will follow in a few months. It includes features that make it easy and convenient to move money, view transactions, check and manage cards, including the re-charge of pre-paid cards and phone tops ups, and initiate instant chat with customer support agents or view the locations of nearest ATMs.

In a highly competitive Italy market, Credem’s new app with its advanced customer interface and user experience will help to enhance the bank’s digital reputation and give it an edge to compete with larger banks and ultimately grow market share.

Temenos Infinity allows Credem to create intuitive and highly engaging digital experiences using a low-code development platform. This simplifies the process, saving time and cost. It also means Credem can reimagine how to engage with its customers in a whole new way through digital and physical channels, creating a consistent and seamless experience.

Temenos Infinity provides a portal for bank staff to manage and assist account holders in their banking journeys. It collects everything the banker needs to know about their account holder in a convenient web-based interface, with data matching that the account holder sees from their own mobile or online interface. Banks using Temenos Infinity saw customer engagement increase by up to 300 percent on their apps in 2020, with the fastest-growing segment being among baby boomers and Gen Xers.

Fabio Caliceti, Head of Digital Channels, Credito Emiliano, commented: “With Temenos, we have been able to quickly develop a mobile banking experience to compete with the very best in Italy. Temenos Infinity gives us the platform we need to efficiently build and manage exceptional digital banking experiences that keep pace with changing customer needs. It is strategic to our digital growth plans and enables us to future-proof our customer relationships.”

David Macdonald, President of Europe, Temenos, said: “Digital innovation in banking is thriving in Italy, and it’s an important market for Temenos where we have a strong and growing presence. So we are delighted Credem has selected our digital banking platform to accelerate its digital strategy. Credem has shown how Temenos Infinity can deliver outstanding digital mobile experiences in a very short timeframe. Customer expectations are constantly evolving, but with the continuous innovation and deployment capabilities of the platform, Credem will always be one step ahead of the competition.”

Credem is running Temenos Infinity on the public cloud with Amazon Web Services to achieve hyperscaler efficiency, security, and resilience for its digital banking services. Temenos Infinity is cloud-native and cloud-agnostic and also available as a SaaS offering on The Temenos Banking Cloud.

Temenos Infinity drives customer acquisition and digital banking engagement with its advanced analytics, enabling financial institutions to increase digital revenues 5x and cut customer onboarding time by 75%. Financial institutions that use Temenos Infinity report a 20% higher Net Promoter Score.

Temenos Infinity is used by over 650 banks worldwide and recognized as a Market Leader in Omdia’s Digital Banking Platform Report and a Leader in Digital Banking Engagement by Forrester.

Following the successful launch of its mobile app, Credem plans to further leverage Temenos Infinity to enhance the customer experience for internet banking later in 2021.

About Credito Emiliano S.p.A.

Credito Emiliano S.p.A. (Credem) is an Italian bank based in Reggio Emilia, Emilia-Romagna. The bank is listed in the Italian Stock Exchange. Credem has more than 6000 employees and presence in different markets:  Banca Credem (retail banking), Credem Banca d’Impresa (corporate banking), Credem Private Banking.

About Temenos

Temenos AG (SIX: TEMN) is the world’s leader in banking software. Over 3,000 banks across the globe, including 41 of the top 50 banks, rely on Temenos to process both the daily transactions and client interactions of more than 1.2 billion banking customers. Temenos offers cloud-native, cloud-agnostic and AI-driven front office, core banking, payments and fund administration software enabling banks to deliver frictionless, omnichannel customer experiences and gain operational excellence.

Temenos software is proven to enable its top-performing clients to achieve cost-income ratios of 26.8% half the industry average and returns on equity of 29%, three times the industry average. These clients also invest 51% of their IT budget on growth and innovation versus maintenance, which is double the industry average, proving the banks’ IT investment is adding tangible value to their business.

For more information, please visit www.temenos.com.

SOURCE Temenos

Related Links

http://www.temenos.com

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.prnewswire.com:443/news-releases/top-italian-bank-credem-goes-live-with-temenos-infinity-in-the-cloud-to-deliver-frictionless-digital-experiences-301316691.html

Continue Reading

PR Newswire

Photocure: Asieris Announces First Patient Administration in Europe within the Phase III Clinical Trial for APL-1702 (Cevira)

Published

on

OSLO, Norway, June 22, 2021 /PRNewswire/ — Photocure ASA (OSE:PHO) today announces that its partner Asieris Pharmaceuticals (Asieris) has administered the first European patient in its phase III clinical trial for APL-1702 (Cevira®).

Asieris announced dosing of the first patient in Europe in its multinational, multicenter, Phase III clinical trial called APRICITY that started last November. The photodynamic drug-device combination product APL-1702, Cevira®, licensed to Asieris by Photocure, is being developed for a novel non-surgical treatment of cervical high-grade squamous intraepithelial lesions (HSIL).

“The multinational phase III clinical trial for Cevira is an important milestone towards a non-surgical treatment of high-grade cervical dysplasia. This step shows once more that our partner Asieris is making great progress and is on track with their clinical program and development of this innovative photodynamic drug-device combination,” says Daniel Schneider, Chief Executive Officer of Photocure.

In China, the clinical trial application for APL-1702, Cevira multinational Phase III trial was approved by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in July 2020. Photocure reported Asieris’ dosing of the first patient in China on November 11, 2020 (https://photocure.com/news/asieris-announces-first-patient-administration-in-the-global-phase-iii-clinical-trial-for-apl-1702-cevira/).

HSIL is a pre-cancerous condition caused by a persistent HPV infection. Each year there are approximately 10 million cases of high-grade disease and over 500,000 new cases of cervical cancer worldwide. In China, approximately 2% of women develop HSIL each year.

Please read Asieris’ full press release here: https://asieris.com/asieris-announces-first-patient-treated-in-europe-in-apricity-the-multinational-phase-iii-clinical-trial-of-apl-1702-cevira/ 

Note to editors:

All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA.

This press release may contain product details and information which are not valid, or a product is not accessible, in your country. Please be aware that Photocure does not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
 

About Cevira

Cevira® is a photodynamic drug-device combination product that is being developed for non-surgical treatment of high-grade cervical dysplasia. Cevira is easily placed on the cervix by the gynecologist and removed by the patient, with no disruption of normal daily activities. Only one or two treatments are needed.

About Cervical dysplasia

High grade cervical squamous intraepithelial lesions (HSIL) is a precancerous condition caused by a persistent HPV infection, a highly prevalent sexually transmitted disease resulting in approximately 10 million cases with high grade disease and > 500 000 new cases of cervical cancer each year. In China, approximately 2% of women have HSIL each year. Currently, surgical excision is the most common treatment option offered to women with cervical high-grade dysplasia. In women of childbearing age in particular there is a high medical need for a non-surgical option which preserves the cervical anatomy and function. No such medical alternative is approved to date.

About Photocure ASA

Photocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com

CONTACT:

Dan Schneider, President and CEO, Photocure ASA
Email: [email protected]

Erik Dahl, CFO, Photocure ASA
Tel: +4745055000
Email: [email protected]

David Moskowitz, Head of Investor Relations, Photocure ASA
Tel: +1 202 280 0888
Email: [email protected]

Media and IR enquiries:

Geir Bjørlo, Corporate Communications (Norway), Photocure ASA
Tel: +47 91540000
Email: [email protected] 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/photocure/r/photocure–asieris-announces-first-patient-administration-in-europe-within-the-phase-iii-clinical-tr,c3371671

The following files are available for download:

SOURCE Photocure

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.prnewswire.com:443/news-releases/photocure-asieris-announces-first-patient-administration-in-europe-within-the-phase-iii-clinical-trial-for-apl-1702-cevira-301316974.html

Continue Reading

PR Newswire

European Wellness Advances Clinical Trials on Precursor Stem Cells for Fertility and Immunology into China

Published

on

In a virtual signing session via Zoom Meeting, the Sino-European alliance agreed to enter into a strategic venture involving European Wellness’ proprietary precursor (progenitor) stem cells and biological peptides at Li Hua Biotechnology’s CGTP research facility and Hunan’s Xiangtan Central Hospital, the first large-scale national first-class general hospital in Xiangtan City. This multi-phase alliance ultimately aims to create best-in-class modern cell therapeutics that are made accessible to the local community in China.

Li Hua Biotechnology was represented by Director Prof. Dr. Tham Xiao Jun, while European Wellness was represented by Group Chairman Prof. Dr. Mike Chan during the June 11th MOU signing.

The partnership manifests European Wellness’ efforts to propel the development of its proprietary patent-pending precursor stem cell therapeutics, which presently is in the early stage of multi-centric clinical development across USA, Greece and Japan led by European Wellness’ international scientific committee which constitutes world-class researchers with profound scientific pedigree including Massachusetts Institute of Technology (MIT), University of Southern California, University of California-Irvine, Oxford University, Cambridge University and Germany’s renowned Heidelberg University, where safety and toxicity studies, and further research studies are undergoing.

The later phase of the strategic venture focalizes on providing education to researchers and local medical practitioners in China, particularly in the specialised subject of bio-regenerative science as well as clinical protocols and best practices in stem cell transplantation.

National Bureau of Statistics of China revealed that China’s birthrate has drastically decline in recent years with only 12 million babies born last year compared to the 18 million born in 2016 (the lowest number of births recorded by China since the 1960s).

“Although in-vitro fertilization (IVF) is a popular option among Chinese couples, it may not always work. The likelihood of IVF success deteriorates after the age of 35,” said Prof. Dr. Mike Chan.

“This is where organ-specific precursor stem cell therapy may be of service as it targets the regeneration of specific organs linked with the pathophysiology of infertility. This is achieved through non-invasive transplantation of a variety of precursor stem cells originating from the pituitary, adrenal gland, liver and the gonads.”

His sentiments were shared by Prof. Tham, China’s renowned gynaecologist with specialisation in IVF and a prominent stem cell scientist since 2005, who believed that this alliance signifies the convergence of great intellects from the East and West in this emerging scientific sphere.

“With China’s three-child policy announced in May 2021 to address the ageing population problem, European Wellness as a pioneer and leader in stem cell therapeutics is indeed a worthy partner to collaborate with and address the escalating demand for non-invasive fertility therapy in China.”

European Wellness Biomedical Group

European Wellness Biomedical Group is an award-winning European group founded in 1991 in Switzerland through the culmination of early cell therapeutic research efforts spanning across Switzerland, Germany, Russia and Austria since the mid ’80s. Today, the Group is most renowned for its pioneering developments in precursor stem cell therapeutics, biological peptides, biological regenerative medicine and immunomodulation. The Group’s multinational business divisions include research and development, bio-manufacturing, medical academy and education, anti-ageing centres and product distribution to practitioners and consumers across 80 countries. The Group also owns a growing network of 26 internationally accredited Wellness Centres globally. Today, the Group is headquartered in Germany and Kota Kinabalu, Malaysia (Asia Pacific) with research facilities in Germany, Switzerland, Czech Republic and United Kingdom.

https://european-wellness.eu

SOURCE European Wellness Biomedical Group

Related Links

https://european-wellness.eu

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.prnewswire.com:443/news-releases/european-wellness-advances-clinical-trials-on-precursor-stem-cells-for-fertility-and-immunology-into-china-301316968.html

Continue Reading
Esports5 days ago

Select Smart Genshin Impact: How to Make the Personality Quiz Work

Esports2 days ago

Dungeons & Dragons: Dark Alliance Voice Actors: Who Voices Utaar?

Blockchain5 days ago

Bitmain Released New Mining Machines For DOGE And LTC

Blockchain2 days ago

Is Margex A Scam?

Esports4 days ago

Genshin Impact Grand Line Conch Locations

Energy3 days ago

Inna Braverman, Founder and CEO of Eco Wave Power Will be Speaking at the 2021 Qatar Economic Forum, Powered by Bloomberg

Esports2 days ago

Valorant Patch 3.00 Agent Tier List

Blockchain2 days ago

Yearn Finance (YFI) and Synthetix (SNX) Technical Analysis: What to Expect?

Blockchain5 days ago

Coinbase Co-Founder Talks DeFi, NFTs, and Crypto Regulation

Blockchain5 days ago

Uniswap Reaches Bearish Exhaustion as Sellers Threaten to Short

Esports5 days ago

Chivalry 2 Crossplay Not Working: Is There a Fix?

AI2 days ago

New Modular SaaS Platform for Financial Services Sector Launched by Ezbob, a Customer Acquisition Tech Provider

HRTech1 day ago

TCS bats for satellite offices, more women in the workforce

Esports1 day ago

Is Dungeons and Dragons: Dark Alliance Crossplay?

Aviation3 days ago

SAS Was The First Airline To Operate A Polar Route

Esports5 days ago

5 Things to Do Before Shadowlands 9.1

Blockchain2 days ago

Cardano, Chainlink, Filecoin Price Analysis: 21 June

Blockchain5 days ago

Crypto coin to be sold at U.S supermarkets

Esports1 day ago

Ruined Pantheon Prestige Edition Splash Art, Price, Release, How to Get

Blockchain4 days ago

Amplifying Her Voice June 22, 10:45AM to June 24, 4:00PM EST BERMUDA

Trending